Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 52Breast Neoplasms 24Lung Neoplasms 21Triple Negative Breast Neoplasms 16Neoplasm Metastasis 16Pancreatic Neoplasms 15Neoplasms 15Colorectal Neoplasms 14Stomach Neoplasms 13Head and Neck Neoplasms 12Esophageal Neoplasms 12Esophageal Squamous Cell Carcinoma 11Uterine Cervical Neoplasms 10Squamous Cell Carcinoma of Head and Neck 10Small Cell Lung Carcinoma 9Rectal Neoplasms 8Ovarian Neoplasms 8Leukemia, Myeloid, Acute 8Recurrence 7Nasopharyngeal Carcinoma 7Glioblastoma 5Fallopian Tube Neoplasms 5Cholangiocarcinoma 5Urinary Bladder Neoplasms 4Sarcoma 4Oropharyngeal Neoplasms 4Mouth Neoplasms 4Lymphoma 4Endometrial Neoplasms 4Colonic Neoplasms 4

Interventions

spartalizumab 1pembrolizumab 1Injections 1Gemcitabine 1Fluorouracil 1Drug Therapy 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Malignant Tumors × Drug Therapy × 1 year × Clear all
NCT05214482 2026-03-03

A Study of AK112 in Advanced Malignant Tumors

Akeso

Phase 1/2 Completed
154 enrolled

Advanced Malignant Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡